- Report
- November 2025
- 168 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- October 2025
- 191 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- October 2025
- 188 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- February 2025
- 200 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- July 2024
- 120 Pages
Global
From €5309EUR$5,950USD£4,681GBP
- Report
- April 2023
- 119 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- November 2021
- 270 Pages
Global
From €2231EUR$2,500USD£1,967GBP
The Peptide Microarray market is a subset of the biotechnology industry that focuses on the development and production of peptide microarrays. These microarrays are used to detect and measure the presence of peptides in a sample, and are used in a variety of research and clinical applications. Peptide microarrays are used to identify biomarkers, measure drug efficacy, and study protein-protein interactions. They are also used to study the effects of post-translational modifications on protein function.
The Peptide Microarray market is highly competitive, with a number of companies offering products and services. Companies in the market include Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more